City Hall
1 Dr. Carlton B. Goodlett
Place
San Francisco, CA 94102-
4689
City and County of San Francisco
Legislation Details
File #:
Version:
1
211072
Name:
Settlement of Lawsuit - Johnson & Johnson - City to
Receive $6 Million to $11 Million Over 9 Years
Status:
Type:
Ordinance
Passed
File created:
In control:
10/19/2021
Clerk of the Board
On agenda:
Final action:
10/19/2021
11/19/2021
Enactment date:
11/19/2021
212-21
Enactment #:
Title:
Ordinance authorizing the partial settlement of the lawsuit filed on behalf of the City and County of
San Francisco and the People of the State of California against Johnson & Johnson and its
subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11
million to be paid over 9 years; the lawsuit was filed on December 18, 2018, in the United States
District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The
City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P.,
Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler
Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the
Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical
Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc.,
Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc,
Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc.,
Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc.,
AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit
involves allegations that Johnson and Johnson’s subsidiary, Janssen Pharmaceuticals, Inc., created a
public nuisance and violated the Unfair Competition Law and the False Advertising Laws through
deceptive marketing of opioids, manufacturing and distributing increasingly large volumes of opioids in
and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and
by failing to prevent and to report suspicious opioid orders as required by state and federal law.
Sponsors:
Attachments:
1. Leg Ver1, 2. Board Pkt 110221, 3. Board Pkt 110921, 4. Leg Final
Action By
Date
Action
Result
Ver.
RECEIVED FROM DEPARTMENT
Clerk of the Board
10/8/2021
1
RECEIVED AND ASSIGNED
President
10/19/2021
1
PASSED ON FIRST READING
Board of Supervisors
11/2/2021
1
Pass
FINALLY PASSED
Board of Supervisors
11/9/2021
1
Pass
APPROVED
Mayor
11/19/2021
1